Clinical Trials Browser

Phase 3 × Interventional × luspatercept × Clear all

NCT04064060 2025-11-12

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Phase 3 Recruiting

Myelodysplastic Syndromes, Myeloproliferative Disorders, beta-Thalassemia

NCT04717414 2025-07-10

INDEPENDENCE

Phase 3 Active not recruiting

Classical hematologyMyeloid

Anemia, Myeloproliferative Disorders, Primary Myelofibrosis

NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

Phase 3 Not yet recruiting

Higher-risk Myelodysplastic Syndrome

NCT02604433 2023-04-18

BELIEVE

Phase 3 Completed

336 enrolled 38 charts 1 FDA

beta-Thalassemia

NCT02631070 2021-12-17

MEDALIST

Phase 3 Completed

229 enrolled 36 charts 1 FDA

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes